A carregar...
Publicação
Hyperbaric oxygen therapy in systemic inflammatory response syndrome
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 973.46 KB | Adobe PDF |
Orientador(es)
Resumo(s)
(1) Background: Systemic inflammatory response syndrome (SIRS) can occur due to a large
number of traumatic or non-traumatic diseases. Hyperbaric oxygen therapy (HBOT) may be used as
a main or adjuvant treatment for inflammation, leading to the main aim of this study, which was to
verify the applicability of HBOT as a safe and tolerable tool in SIRS-positive dogs. (2) Methods: This
prospective cohort study included 49 dogs who showed two or more parameters of SIRS, divided
into the Traumatic Study Group (n = 32) and the Non-Traumatic Study Group (n = 17). All dogs were
submitted to HBOT for 60–90 min sessions, with 2.4–2.8 ATA. (3) Results: This study revealed that
73.5% (36/49) of dogs showed improvement, and the minimum number of HBOT sessions was two,
with a mean of 12.73. The number of days between diagnosis and the beginning of HBOT showed
statistical significance (p = 0.031) relative to the clinical outcome. No dogs showed any major side
effects. (4) Conclusions: We concluded that HBOT may be safe and tolerable for SIRS-positive dogs,
and that it should be applied as early as possible.
Descrição
Research Areas: Veterinary Sciences
Palavras-chave
SIRS HBOT traumatic dogs ATA
Contexto Educativo
Citação
Gouveia D, Chichorro M, Cardoso A, Carvalho C, Silva C, Coelho T, Dias I, Ferreira A, Martins Â. 2022. Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome. Veterinary Sciences, 9(2):33. DOI: https://doi.org/10.3390/vetsci9020033
Editora
MDPI